Patrick F. Smith, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 38,208 shares at $21.55 ($823K) on 2023-06-05, disclosed to the SEC on 2023-06-06.
Scheduled sale ($823k) by PRESIDENT, INTEGRATED DRUG Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.55 | 19,104 | $412K | 50.0% |
| 2 | $21.55 | 19,104 | $412K | 50.0% |
| Total | $21.55 avg | 38,208 | $823K | 100% |
| Filing → |
| CERT | SELL | 2024-02-21 | $90K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |
| CERT | SELL | 2022-08-18 | $177K | — | Filing → |